Eudaimonia Partners’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,002
Closed -$340K 922
2020
Q3
$340K Sell
4,002
-4
-0.1% -$202 0.09% 217
2020
Q2
$142K Buy
4,006
+1,818
+83% +$53.2K 0.05% 285
2020
Q1
$29K Buy
+2,188
New +$36.8K 0.01% 581

Eudaimonia Partners's IMMU Position: Q4 2020 in Review

Eudaimonia Partners sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,002 shares — an estimated $340K sold.

Eudaimonia Partners first reported a position in IMMU in Q1 2020 and held it in 3 quarters. The position peaked at $340K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Eudaimonia Partners reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Eudaimonia Partners sold 4,002 Immunomedics Inc shares in Q4 2020, an estimated $340K.
  • Eudaimonia Partners first reported a position in Immunomedics Inc in Q1 2020 and held it in 3 quarters.
  • Eudaimonia Partners's Immunomedics Inc position peaked at $340K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Eudaimonia Partners's 13F filing for Q4 2020, filed 18 Feb 2021.